Australia markets closed

Pulse Biosciences, Inc. (PLSE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
11.19+0.18 (+1.63%)
At close: 04:00PM EDT
11.46 +0.27 (+2.41%)
After hours: 07:44PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-42,546
-42,210
-58,505
-63,660
-49,851
-
Depreciation & amortisation
1,204
1,207
1,355
1,146
1,095
-
Stock-based compensation
8,044
7,181
5,191
14,601
10,075
-
Change in working capital
-2,966
768
-3,716
-6,197
3,200
-
Accounts receivable
-
0
61
-61
0
-
Inventory
-
0
-2,653
-5,824
0
-
Accounts payable
-448
263
-1,304
1,160
-266
-
Other working capital
-36,338
-33,162
-47,414
-54,534
-35,806
-
Net cash provided by operating activities
-36,251
-33,041
-47,013
-54,097
-35,365
-
Cash flows from investing activities
Investments in property, plant and equipment
-87
-121
-401
-437
-441
-
Purchases of investments
-
-
0
0
-29,025
-77,993
Sales/maturities of investments
-
-
0
8,000
39,510
68,500
Net cash used for investing activities
-87
-121
-401
7,563
10,044
-
Cash flows from financing activities
Debt repayment
-
-
-437
-1,532
0
0
Common stock issued
5
0
14,864
56,697
29,434
-
Other financing activities
-
-6
-437
-232
-
-613
Net cash used provided by (used for) financing activities
17,125
16,388
79,939
62,685
30,885
-
Net change in cash
-19,213
-16,774
32,525
16,151
5,564
-
Cash at beginning of period
54,098
61,139
28,614
12,463
6,899
-
Cash at end of period
34,885
44,365
61,139
28,614
12,463
-
Free cash flow
Operating cash flow
-36,251
-33,041
-47,013
-54,097
-35,365
-
Capital expenditure
-87
-121
-401
-437
-441
-
Free cash flow
-36,338
-33,162
-47,414
-54,534
-35,806
-